Rosen Howard B 4
4 · Kala Pharmaceuticals, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Rosen Howard B
Director
Transactions
- Award
Common Stock
2021-06-17+20,000→ 44,824 total
Holdings
- 8,240(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021.
- [F2]Includes 20,000 unvested RSUs.
- [F3]These shares are owned directly by the Rosen/Doherty Revocable Trust Dated 6/11/01 (the "Trust"), and indirectly by Mr. Rosen as co-trustee of the Trust.